Passer au contenu principal

Test de dépistage néonatal

Heel prick test

Mothers of all newborn babies are offered testing for certain rare but serious health conditions by testing blood taken from the baby's heel. This is the blood spot screening programme and it is also known as the heel prick test.

En un coup d'œil

  • The newborn blood spot test is also known as the heel prick test.

  • Un petit échantillon de sang est prélevé du talon du bébé lorsqu'il a 5 jours.

  • Le test dépiste les troubles sanguins héréditaires et d'autres affections rares.

  • Ces conditions incluent la drépanocytose, la fibrose kystique et la phénylcétonurie.

  • Un diagnostic et un traitement précoces peuvent améliorer les résultats pour ces conditions.

How is the blood test done?

This is usually done by a health professional (usually a midwife or health visitor) during a home visit when your baby is 5 days old. A very small sample of blood is collected by pricking your baby's heel, using a special device and squeezing out a few drops of blood on to a blood spot card. Although this test may be uncomfortable, it is over very quickly. The sample is sent away for testing, and you will receive the results by letter or phone in due course.

It is important that you tell your healthcare professional if you, your partner or a member of your family have been diagnosed with one of the conditions below.

Which conditions might be tested for by the heel prick test?

Conditions which the heel prick test can screen for are as follows:

  • Drépanocytose (SCD) - this is an inherited blood disorder. Treatment started early in life, can prevent complications. This may include taking regular antibiotics and having extra vaccinations.

  • Mucoviscidose (CF) - this is an inherited disorder that affects the internal organs, especially the lungs and digestive system. The heel prick test detects a chemical called immunoreactive trypsinogen. This is high in babies with cystic fibrosis. If it is high then a sweat test and genetic test are usually done to confirm the diagnosis. The earlier the diagnosis is made, the sooner treatment can begin which improves the outlook (prognosis).

  • Phenylketonuria - this is a very rare condition in which the body is unable to break down a substance called phenylalanine, which builds up in the blood and brain. It is really important for this to be picked up early. Early treatment significantly reduces the risk of brain problems and complications in the future.

  • Congenital hypothyroidism - this is a rare condition which can lead to impaired growth and mental development. However, treated babies can develop normally so it is important for it to be diagnosed early. If your baby was born prematurely (under 32 weeks) then your baby will need a repeat test when they are 28 days old.

  • Medium-chain acyl-Co-A dehydrogenase deficiency (MCADD)- this is a very rare, but potentially life-threatening, inherited disorder, where fat cannot be broken down by the body as well as usual. Babies with this condition develop normally, but recognising the condition early enables parents to make sure their babies and children with this condition eat regularly. When people with this condition go for a long period of time without eating there is a build-up of medium-chain fats inside the body, which can have a poisonous effect. Also, a sudden and severe drop in blood sugar levels can occur.

  • All four devolved nations of the United Kingdom now offer screening for four other serious, but treatable, inherited metabolic diseases. These are:

    • Homocystinuria (HCU).

    • Maple syrup urine disease (MSUD).

    • Glutaric aciduria type 1 (GA1).

    • Isovaleric acidaemia (IVA).

If you do not want your baby to have some or all of these conditions tested for in the heel prick test then you should inform your doctor or midwife.

Questions fréquemment posées

Que vérifie spécifiquement le test de piqûre au talon ?

Le test de dépistage par piqûre au talon permet de détecter plusieurs affections graves, notamment la drépanocytose (SCD), la fibrose kystique (CF), la phénylcétonurie, l'hypothyroïdie congénitale et le déficit en acyl-CoA déshydrogénase des acides gras à chaîne moyenne (MCADD). Il dépiste également quatre autres maladies métaboliques héréditaires : l'homocystinurie (HCU), la maladie de l'urine à odeur de sirop d'érable (MSUD), l'acidurie glutarique de type 1 (GA1) et l'acidémie isovalérique (IVA).

Lectures complémentaires et références

À propos de l'auteurVoir la biographie complète

Image de l'auteur

Dr Hayley Willacy, FRCGP

Médecin généraliste, Auteur médical

MBChB (1992), DRCOG, DFFP, MRCOG (Part 1) MRCGP (2007), DFSRH (2013), MSc - medical education (2020)

Le Dr Hayley Willacy était médecin généraliste au NHS travaillant dans le nord-ouest de l'Angleterre, qui a pris sa retraite de la pratique clinique en 2022 après 30 ans. 

À propos du critiqueVoir la biographie complète

Image de l'auteur

Dr Colin Tidy, MRCGP

Médecin généraliste, Auteur médical

MBBS, MRCGP, MRCP (Paediatrics), DCH

Le Dr Colin Tidy est un médecin du NHS, basé dans l'Oxfordshire.

Historique de l'article

Les informations sur cette page sont rédigées et examinées par des cliniciens qualifiés.

vérificateur d'éligibilité à la grippe

Demandez, partagez, connectez-vous.

Parcourez les discussions, posez des questions et partagez vos expériences sur des centaines de sujets de santé.

vérificateur de symptômes

Vous ne vous sentez pas bien ?

Évaluez vos symptômes en ligne gratuitement

Inscrivez-vous à la newsletter Patient

Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.

Veuillez entrer une adresse e-mail valide

En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.